These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24841856)

  • 1. Oncogenic transformation tunes the cross-talk between mesenchymal stem cells and T lymphocytes.
    Sánchez N; Miranda A; Funes JM; Hevia G; Pérez R; de León J
    Cell Immunol; 2014; 289(1-2):174-84. PubMed ID: 24841856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.
    Duffy MM; Pindjakova J; Hanley SA; McCarthy C; Weidhofer GA; Sweeney EM; English K; Shaw G; Murphy JM; Barry FP; Mahon BP; Belton O; Ceredig R; Griffin MD
    Eur J Immunol; 2011 Oct; 41(10):2840-51. PubMed ID: 21710489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGE2 contributes to in vitro MSC-mediated inhibition of non-specific and antigen-specific T cell proliferation in MS patients.
    Zafranskaya M; Nizheharodava D; Yurkevich M; Ivanchik G; Demidchik Y; Kozhukh H; Fedulov A
    Scand J Immunol; 2013 Nov; 78(5):455-62. PubMed ID: 23944654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.
    Mazzoni A; Bronte V; Visintin A; Spitzer JH; Apolloni E; Serafini P; Zanovello P; Segal DM
    J Immunol; 2002 Jan; 168(2):689-95. PubMed ID: 11777962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells.
    Martinet L; Fleury-Cappellesso S; Gadelorge M; Dietrich G; Bourin P; Fournié JJ; Poupot R
    Eur J Immunol; 2009 Mar; 39(3):752-62. PubMed ID: 19197941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cells augment CD4+ and CD8+ T-cell proliferation through a CCL2 pathway.
    Zhou Y; Day A; Haykal S; Keating A; Waddell TK
    Cytotherapy; 2013 Oct; 15(10):1195-207. PubMed ID: 23845188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
    Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
    Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stromal cells derived from CD271(+) bone marrow mononuclear cells exert potent allosuppressive properties.
    Kuçi Z; Kuçi S; Zircher S; Koller S; Schubert R; Bönig H; Henschler R; Lieberz R; Klingebiel T; Bader P
    Cytotherapy; 2011 Nov; 13(10):1193-204. PubMed ID: 21905954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 regulates the proliferation, differentiation and spontaneous transformation of mesenchymal stem cells.
    Armesilla-Diaz A; Elvira G; Silva A
    Exp Cell Res; 2009 Dec; 315(20):3598-610. PubMed ID: 19686735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human mesenchymal stromal cells modulate T-cell responses through TNF-α-mediated activation of NF-κB.
    Dorronsoro A; Ferrin I; Salcedo JM; Jakobsson E; Fernández-Rueda J; Lang V; Sepulveda P; Fechter K; Pennington D; Trigueros C
    Eur J Immunol; 2014 Feb; 44(2):480-8. PubMed ID: 24307058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells.
    Hegyi B; Kudlik G; Monostori E; Uher F
    Biochem Biophys Res Commun; 2012 Mar; 419(2):215-20. PubMed ID: 22333568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity.
    Lei J; Wang Z; Hui D; Yu W; Zhou D; Xia W; Chen C; Zhang Q; Wang Z; Zhang Q; Xiang AP
    Cell Immunol; 2011; 271(1):147-56. PubMed ID: 21757189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells induce apoptosis of activated T cells.
    Plumas J; Chaperot L; Richard MJ; Molens JP; Bensa JC; Favrot MC
    Leukemia; 2005 Sep; 19(9):1597-604. PubMed ID: 16049516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Licensing by Inflammatory Cytokines Abolishes Heterogeneity of Immunosuppressive Function of Mesenchymal Stem Cell Population.
    Szabó E; Fajka-Boja R; Kriston-Pál É; Hornung Á; Makra I; Kudlik G; Uher F; Katona RL; Monostori É; Czibula Á
    Stem Cells Dev; 2015 Sep; 24(18):2171-80. PubMed ID: 26153898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines.
    Chen HW; Chen HY; Wang LT; Wang FH; Fang LW; Lai HY; Chen HH; Lu J; Hung MS; Cheng Y; Chen MY; Liu SJ; Chong P; Lee OK; Hsu SC
    J Immunol; 2013 May; 190(10):5065-77. PubMed ID: 23589610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative immunomodulatory properties of adipose-derived mesenchymal stem cells conditioned media from BALB/c, C57BL/6, and DBA mouse strains.
    Hashemi SM; Hassan ZM; Pourfathollah AA; Soudi S; Shafiee A; Soleimani M
    J Cell Biochem; 2013 Apr; 114(4):955-65. PubMed ID: 23225199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15.
    Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC
    Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect.
    Choi YS; Jeong JA; Lim DS
    Immunol Invest; 2012; 41(2):214-29. PubMed ID: 22017637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.